Literature DB >> 8323772

Brachytherapy for non-metastatic squamous cell carcinoma of the buccal mucosa. An analysis of forty-five cases treated with permanent implants.

H Shibuya1, M Takeda, S Matsumoto, M Hoshina, M Shagdarsuren, S Suzuki.   

Abstract

An analysis has been undertaken of 45 patients with non-metastatic squamous cell carcinoma of the buccal mucosa treated by permanent 198Au or 222Rn implants and in most cases supplementary external irradiation. Eight patients had T1, 30 had T2, and 7 T3 disease. Of the lesions 21 were located in the buccal mucosal surface, 14 in the retromolar region, and 10 in the bucco-alveolar sulci. Seven of the 45 (16%) died of the disease and the actuarial 5-year survival rate was 81%. No obvious differences were noted in survival rate between different stages of the disease or between different subsites of the primary lesion. There were 6 local recurrences occurring from 3 to 33 months after treatment, and only one of these was salvageable by further radiation therapy. Neck node metastasis occurred in 11 cases from 2 to 34 months after treatment, and 8 of these cases responded successfully to a radical neck dissection or radiotherapy.

Entities:  

Mesh:

Year:  1993        PMID: 8323772     DOI: 10.3109/02841869309093604

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

1.  Disease control using low-dose-rate brachytherapy is unaffected by comorbid severity in oral cancer patients.

Authors:  R Yoshimura; H Shibuya; K Hayashi; K Toda; H Watanabe; M Miura
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

Review 2.  Current status and perspectives of brachytherapy for head and neck cancer.

Authors:  Hitoshi Shibuya
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.402

3.  A buccal mucosa carcinoma treated with high dose rate brachytherapy.

Authors:  Joann I Prisciandaro; Robert L Foote; Michael G Herman; Sally J Lee; Wayne N LaJoie; Andrew B Van Blarcom; Peter D Yeakel
Journal:  J Appl Clin Med Phys       Date:  2005-01-12       Impact factor: 2.102

4.  Dose coverage comparison between "interstitial catheter-only" and "hybrid intracavitary-interstitial brachytherapy" for early stage squamous cell carcinoma of the buccal mucosa.

Authors:  Naoya Murakami; Takao Ueno; Wakako Yatsuoka; Hiroyuki Okamoto; Nikolaos Tselis; Koji Masui; Ken Yoshida; Kana Takahashi; Koji Inaba; Kae Okuma; Hiroshi Igaki; Yuko Nakayama; Jun Itami
Journal:  J Contemp Brachytherapy       Date:  2018-10-31

Review 5.  Is There Still a Place for Brachytherapy in the Modern Treatment of Early-Stage Oral Cancer?

Authors:  Luboš Tuček; Milan Vošmik; Jiří Petera
Journal:  Cancers (Basel)       Date:  2022-01-03       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.